| Daniel W Cotten, MD | |
|
907 E Lamar Alexander Pkwy, Maryville, TN 37804-5015 | |
| (865) 977-5567 | |
| (865) 980-4962 |
| Full Name | Daniel W Cotten |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 36 Years |
| Location | 907 E Lamar Alexander Pkwy, Maryville, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215997978 | NPI | - | NPPES |
| 64720824 | Medicaid | KY | |
| 300125492 | Other | TN | RR MEDICARE |
| 40222337 | Other | TN | BC/BS OF TN |
| 3074299 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 19949 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Blount Memorial Hospital | Maryville, TN | Hospital |
| University Of Tn Medical Center | Knoxville, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Leconte Radiology Pc | 1850373705 | 30 |
News Archive
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced preliminary data from a single site participating in the multicenter Phase 2 clinical trial that showed that Positron Emission Tomography (PET) imaging with its novel investigational agent flurpiridaz F 18 injection (formerly known as BMS747158) provided better image quality than technetium-99m sestamibi single photon emission computed tomography (SPECT), the current standard for the non-invasive detection of coronary artery disease (CAD).
Heart attack victims who live outside Ottawa's urban centre now are part of the University of Ottawa Heart Institute's (UOHI) far-reaching emergency life-saving program, ensuring urgent standardized treatment regardless of geography and, for the first time in Ontario, throughout an entire regional health district.
The Salk Institute scientist who earlier discovered that enhancing the function of a single protein produced a mouse with an innate resistance to weight gain and the ability to run a mile without stopping has found new evidence that this protein and a related protein play central roles in the body's complex journey to obesity and offer a new and specific metabolic approach to the treatment of obesity related disease such as Syndrome X (insulin resistance, hyperlipidemia and atherosclerosis).
Significant comparative effectiveness research (CER) efforts should be dedicated to understanding the effectiveness of investments across broad determinants of health instead of focusing primarily within the health care domain alone (David Kindig and John Mullahy, 8/25).
› Verified 4 days ago
| Entity Name | Leconte Radiology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447210109 PECOS PAC ID: 1850373705 Enrollment ID: O20040603001088 |
News Archive
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced preliminary data from a single site participating in the multicenter Phase 2 clinical trial that showed that Positron Emission Tomography (PET) imaging with its novel investigational agent flurpiridaz F 18 injection (formerly known as BMS747158) provided better image quality than technetium-99m sestamibi single photon emission computed tomography (SPECT), the current standard for the non-invasive detection of coronary artery disease (CAD).
Heart attack victims who live outside Ottawa's urban centre now are part of the University of Ottawa Heart Institute's (UOHI) far-reaching emergency life-saving program, ensuring urgent standardized treatment regardless of geography and, for the first time in Ontario, throughout an entire regional health district.
The Salk Institute scientist who earlier discovered that enhancing the function of a single protein produced a mouse with an innate resistance to weight gain and the ability to run a mile without stopping has found new evidence that this protein and a related protein play central roles in the body's complex journey to obesity and offer a new and specific metabolic approach to the treatment of obesity related disease such as Syndrome X (insulin resistance, hyperlipidemia and atherosclerosis).
Significant comparative effectiveness research (CER) efforts should be dedicated to understanding the effectiveness of investments across broad determinants of health instead of focusing primarily within the health care domain alone (David Kindig and John Mullahy, 8/25).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel W Cotten, MD Po Box 1445, Indianapolis, IN 46206-1445 Ph: (866) 388-2916 | Daniel W Cotten, MD 907 E Lamar Alexander Pkwy, Maryville, TN 37804-5015 Ph: (865) 977-5567 |
News Archive
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced preliminary data from a single site participating in the multicenter Phase 2 clinical trial that showed that Positron Emission Tomography (PET) imaging with its novel investigational agent flurpiridaz F 18 injection (formerly known as BMS747158) provided better image quality than technetium-99m sestamibi single photon emission computed tomography (SPECT), the current standard for the non-invasive detection of coronary artery disease (CAD).
Heart attack victims who live outside Ottawa's urban centre now are part of the University of Ottawa Heart Institute's (UOHI) far-reaching emergency life-saving program, ensuring urgent standardized treatment regardless of geography and, for the first time in Ontario, throughout an entire regional health district.
The Salk Institute scientist who earlier discovered that enhancing the function of a single protein produced a mouse with an innate resistance to weight gain and the ability to run a mile without stopping has found new evidence that this protein and a related protein play central roles in the body's complex journey to obesity and offer a new and specific metabolic approach to the treatment of obesity related disease such as Syndrome X (insulin resistance, hyperlipidemia and atherosclerosis).
Significant comparative effectiveness research (CER) efforts should be dedicated to understanding the effectiveness of investments across broad determinants of health instead of focusing primarily within the health care domain alone (David Kindig and John Mullahy, 8/25).
› Verified 4 days ago
Katherine Jeanne Talmont, RDMS, RT(R)(CT) Radiology Medicare: Not Enrolled in Medicare Practice Location: 907 E Lamar Alexander Pkwy, Maryville, TN 37804 Phone: 865-981-2148 | |
Dr. Maikel Elia Botros, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 907 E Lamar Alexander Pkwy, Maryville, TN 37804 Phone: 865-977-5534 Fax: 865-981-2154 | |
Kevin Liaw, M.D Radiology Medicare: Accepting Medicare Assignments Practice Location: 907 E Lamar Alexander Pkwy, Maryville, TN 37804 Phone: 865-983-7211 | |
John G Niethammer Iii, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 907 E Lamar Alexander Pkwy, Maryville, TN 37804 Phone: 865-977-5567 Fax: 865-980-4962 | |
Kevin James Sentell, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 907 E Lamar Alexander Pkwy, Maryville, TN 37804 Phone: 865-977-5567 Fax: 865-980-4962 | |
Dr. Kristen Nicole Carver, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 907 E Lamar Alexander Pkwy, Maryville, TN 37804 Phone: 865-977-5567 Fax: 865-980-4962 |